Project Details
Description
Summary not available
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/04 → 31/12/08 |
Collaborative partners
- University of Liège (ULiège) (Coordinator) (lead)
- The Chancellor, Masters And Scholars of the University Of Oxford (Project partner)
- Apeiron Biologics (Project partner)
- University of Birmingham (Project partner)
- Centre Hospitalier Regional et Universitaire de Lille (Project partner)
- French National Centre for Scientific Research (CNRS) (Project partner)
- Deutsches Krebsforschungszentrum Heildeberg-German Cancer Research Center (Project partner)
- Fit Biotech Oyj PLC (Project partner)
- Ingenium Pharmaceuticals AG (Project partner)
- French National Institute of Health and Medical Research (Project partner)
- King's College London (Project partner)
- Max Planck Society (Project partner)
- Austrian Academy of Sciences (Project partner)
- Research Institute of Molecular Pathology (Project partner)
- University of Basel (Project partner)
- University of Montreal (UdeM) (Project partner)
- Tartu Ülikool (University of Tartu) (Project partner)
- Sapienza University of Rome (Project partner)
- Bayerische Julius-Maximilians-Universität Würzburg (Project partner)
- The Walter and Eliza Hall Institute for Medical Research (Project partner)
- Zentech (Project partner)
Funding
- European Commission (EC): €12,000,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.